Emergent BioSolutions (EBS) Prepaid Assets (2010 - 2026)

Emergent BioSolutions' Prepaid Assets history runs 17 years deep, the most recent figure standing at $26.9 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 10.93% year-over-year to $26.9 million in Q1 2026; TTM through Mar 2026 was $26.9 million, a 10.93% decrease from a year earlier, with the FY2025 full-year figure at $25.8 million, down 4.09% from the prior year.
• Prepaid Assets rose to $26.9 million in Q1 2026 per EBS's latest filing, from $25.8 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $139.9 million in Q3 2022 and bottomed at $24.0 million in Q2 2025.
• The 5-year median for Prepaid Assets is $41.7 million (2023), against an average of $52.6 million.
• Across the five-year window, Prepaid Assets surged 93.84% in 2022 and slumped 64.35% in 2023, its largest moves.
• Year by year, Prepaid Assets stood at $57.9 million in 2022, then decreased by 17.27% to $47.9 million in 2023, then sank by 43.84% to $26.9 million in 2024, then slipped by 4.09% to $25.8 million in 2025, then advanced by 4.26% to $26.9 million in 2026.
• Per Business Quant, the three latest EBS Prepaid Assets figures stand at $26.9 million (Q1 2026), $25.8 million (Q4 2025), and $25.6 million (Q3 2025).